- Home
- TCBI vs RXRX Comparison
TCBI vs RXRX Comparison
Compare TCBI & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBI
- RXRX
- Stock Information
- Founded
- TCBI 1996
- RXRX 2013
- Country
- TCBI United States
- RXRX United States
- Employees
- TCBI N/A
- RXRX N/A
- Industry
- TCBI Major Banks
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- TCBI Finance
- RXRX Health Care
- Exchange
- TCBI Nasdaq
- RXRX Nasdaq
- Market Cap
- TCBI 2.9B
- RXRX 2.6B
- IPO Year
- TCBI N/A
- RXRX 2021
- Fundamental
- Price
- TCBI $66.03
- RXRX $5.50
- Analyst Decision
- TCBI Hold
- RXRX Buy
- Analyst Count
- TCBI 14
- RXRX 5
- Target Price
- TCBI $79.29
- RXRX $8.20
- AVG Volume (30 Days)
- TCBI 670.7K
- RXRX 23.6M
- Earning Date
- TCBI 04-17-2025
- RXRX 05-08-2025
- Dividend Yield
- TCBI N/A
- RXRX N/A
- EPS Growth
- TCBI N/A
- RXRX N/A
- EPS
- TCBI 1.74
- RXRX N/A
- Revenue
- TCBI $891,496,000.00
- RXRX $58,839,000.00
- Revenue This Year
- TCBI $44.91
- RXRX $57.30
- Revenue Next Year
- TCBI $8.85
- RXRX $47.96
- P/E Ratio
- TCBI $38.04
- RXRX N/A
- Revenue Growth
- TCBI N/A
- RXRX 32.00
- 52 Week Low
- TCBI $55.46
- RXRX $3.79
- 52 Week High
- TCBI $91.80
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- TCBI 42.21
- RXRX 48.15
- Support Level
- TCBI $59.37
- RXRX $5.14
- Resistance Level
- TCBI $68.22
- RXRX $6.00
- Average True Range (ATR)
- TCBI 4.22
- RXRX 0.58
- MACD
- TCBI -0.08
- RXRX 0.15
- Stochastic Oscillator
- TCBI 39.45
- RXRX 77.38
About TCBI Texas Capital Bancshares Inc.
Texas Capital Bancshares Inc is a secured lender, with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. The company's national lines of business provide specialized lending products to businesses throughout the United States. The bank operates in Texas' main metropolitan areas, like Austin, Dallas, Fort Worth, Houston, and San Antonio.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.